NYSE: ARMP - Armata Pharmaceuticals, Inc.

Yield per half year: -30.38%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Armata Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp.

more details
for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2011-03-09
ISIN US04216R1023
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.armatapharma.com
Цена ао 1.65
Change price per day: 0% (1.65)
Change price per week: -7.82% (1.79)
Change price per month: -22.9% (2.14)
Change price per 3 month: -21.8% (2.11)
Change price per half year: -30.38% (2.37)
Change price per year: -60.53% (4.18)
Change price per 3 year: -69.22% (5.36)
Change price per 5 year: -58.85% (4.01)
Change price per year to date: -15.38% (1.95)
All parameters

Underestimation

Title Value Grade
P/S 18.4 1
P/BV -2.6 0
P/E 0 0
EV/EBITDA -4.76 0
Total: 3.13

Efficiency

Title Value Grade
ROA, % -62.79 0
ROE, % 215.33 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -2.3 10
Total: 7.8

Growth impulse

Title Value Grade
Yield Revenue, % 14509.68 10
Yield Ebitda, % 119.33 10
Yield EPS, % -19.58 0
Total: 8
More

Institutions Volume Share, %
Bank of America Corporation 634451 1.76
Vanguard Group Inc 145078 0.4
Bridgeway Capital Management, Inc. 110382 0.31
Geode Capital Management, LLC 101013 0.28
Edgewood Management Llc 100000 0.28
Renaissance Technologies, LLC 53596 0.15
State Street Corporation 40300 0.11
Qube Research & Technologies Ltd 23563 0.07
Blackrock Inc. 22760 0.06
Northern Trust Corporation 19380 0.05

ETFShare, %Profitability for 1 year, %Dividends, %
iShares Micro-Cap ETF 0.00569 -13.97 1.54048
0.01-13.971.54



Head Job title Payment Year of birth
Dr. Mina Pastagia M.D., MS Chief Medical Officer 463.75k 1975 (50 years)
Dr. Deborah L. Birx M.D. CEO & Director 536.43k 1957 (68 years)
Dr. Pierre Kyme Ph.D. Chief Business Officer N/A
Mr. Peter Hubbard Vice President of Operations N/A
Mr. David House Senior VP of Finance & Principal Financial Officer

Address: United States, Marina del Rey. CA, 4503 Glencoe Avenue - open in Google maps, open in Yandex maps
Website: https://www.armatapharma.com